SIGN UP
LOG IN
I
IMVT
Immunovant Inc
14.46
-0.10-0.69%After Hours: 14.50 +0.04 +0.28%17:27 05/23 EDT
OPEN/PREV CLOSE14.19/14.56
TODAY RANGE14.11-14.48
VOL754.63K
MARKET CAP2.46B
52 WEEK RANGE12.72-34.47
AVG VOL (3M)1.70M
% TURNOVER0.44%
TURNOVER--
P/E (TTM)-5.5296
% RANGE2.51%
EPS(TTM)-2.6150
P/E(FORWARD)-5.1368
P/B6.04
BVPS2.395
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP967.88M
SHARES OUTSTANDING169.86M
NEXT EARNINGS05/30-06/06
FREE FLOAT66.94M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·05/09 12:02
Argenx Q1 Earnings: Less Than Perfect Report Gets Punished
TipRanks·04/26 13:03
Gran Tierra, Immunovant, AIM, Cracker Barrel, JB Hunt: Insider Moves Unveiled!
TipRanks·04/26 02:04
Insider Moves: Immunovant Executives Cash In on Stocks
TipRanks·04/23 06:37
Immunovant’s Strategic Leadership and Portfolio Expansion Justify Buy Rating
Benzinga·04/22 13:37
Charles Schwab To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday
Dow Jones·04/22 12:08
Immunovant Price Target Cut to $17.00/Share From $38.00 by UBS
Dow Jones·04/22 12:08
Immunovant Cut to Neutral From Buy by UBS
Benzinga·04/22 11:58
UBS Downgrades Immunovant to Neutral, Lowers Price Target to $17
TipRanks·04/22 10:12
Immunovant downgraded to Neutral from Buy at UBS
TipRanks·04/22 09:27
Immunovant’s Strategic Developments and Growth Potential Drive Buy Rating
TipRanks·04/21 20:05
Immunovant’s Strategic Advancements and Targeted Approach Drive Buy Rating
TipRanks·04/21 11:48
Immunovant Announces New CEO Amid Strategic Shift
Seeking Alpha·04/21 11:46
Immunovant makes leadership changes
Dow Jones·04/21 11:44
Immunovant CEO Salzmann Retires; Roivant Exec Venker Takes the Helm
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.